Analyst Consensus ?
ConsensusHold22 ratings
Bullish1045.5%
Neutral1045.4%
Bearish29.1%
Ameriprise Financial, Inc. · AMP · FY2026 Q3 · Calendar Q4 2026
Ameriprise posts strong Q3 as AI investment and advisor growth accelerate
Ameriprise's Q3 supports a constructive operating trajectory: asset growth, advisor productivity and financial-institution partnerships are strengthening the franchise, while AI investment broadens future capacity. The main counterweights are recruiting costs, softer institutional and fixed-income flows, and market sensitivity.
Reported Before market openNYSEFinancial Services
$43.98B market cap
100quality score
Earnings scorecard
Reported versus consensus
Reported EPS
$11.26
Consensus $11.77
EPS surprise
-4.3%
Reported versus consensus
Reported revenue
$5.08B
Consensus $5.10B
Revenue surprise
-0.5%
Reported versus consensus
Market reaction
prior-close to event-session close
Stock move
+1.7%
Event window
SPY move
-0.4%
Same window
Abnormal move
+2.0%
Stock minus SPY
Volume
1.5×
Versus trailing sessions
Subsequent drift
0.0%
Up to 20 sessions
AMPSPY benchmark
Ask FN2 about AMP FY2026 Q3
Transcript, numbers and history already loaded
Why did AMP rise 1.7% after missing EPS estimates in FY2026 Q3?What changed in AMP's guidance and outlook in FY2026 Q3?Give me the bull and bear case for AMP after FY2026 Q3 earnings.
Free account. Your question opens in FN2 with this report's transcript and numbers attached.
Transcript intelligence
What changed
Management highlighted continued growth in assets, revenue, EPS and advisor productivity; introduced early-release AI meeting-prep and service-assistant tools; and expanded capital-return capacity with a new repurchase authorization. Huntington Bank remains a major advisor-asset addition, with Cadence Bank planned for 2027.
Guidance delta
Guidance sentiment was maintained. Management's forward priorities point to broader AI workflows in 2027, additional premium equity-income and alternative offerings, continued financial-institution team acquisitions, and ongoing share repurchases.
Key takeaways
- Operating momentum remained strong, with higher assets, revenue, EPS and return on equity.
- Advisor productivity reached a record level, supported by recruiting, retention and technology investment.
- Huntington and Cadence expand the financial-institution partnership pipeline.
- Capital allocation and AI investment both increased, but flows and recruiting economics remain important watch points.
Management priorities
- Deepen AI capabilities through data integration and automated workflows in 2027.
- Expand premium equity-income, alternative and public-private investment offerings.
- Continue financial-institution advisor acquisitions and maintain share repurchases.
Follow AMP with an agent that reads every filing, transcript, and price print. Free to start.
Try FN2 freeEarnings History
Estimate
Beat
Miss
Match
Analyst 52W Price Targets
$497.9Current
$330Low
$509.11Average
$645High
Latest persisted target per named analyst; persisted current price from FN2's market snapshot as of Oct 30, 2026. Not an FN2 forecast.
Firm-level rating actions
FMP grade actions identify the grading firm, not a named analyst.
| Firm | Rating | Prior rating | Action | Date |
|---|---|---|---|---|
| B of A Securities | Underperform | Buy | Downgrade | Oct 19, 2026 |
| Morgan Stanley | Underweight | Underweight | Maintain | Oct 9, 2026 |
| Evercore ISI Group | In Line | In Line | Maintain | Oct 7, 2026 |
| BMO Capital | Market Perform | Market Perform | Maintain | Oct 6, 2026 |
| Argus Research | Buy | Buy | Maintain | Jul 31, 2026 |
| RBC Capital | Outperform | Outperform | Maintain | Jul 24, 2026 |
| Keefe, Bruyette & Woods | Market Perform | Market Perform | Maintain | Jul 24, 2026 |
| Piper Sandler | Neutral | Neutral | Maintain | Jul 13, 2026 |
| Jefferies | Buy | Buy | Maintain | Jul 10, 2026 |
| William Blair | Market Perform | Outperform | Downgrade | Jul 25, 2025 |
| Raymond James | Strong Buy | Strong Buy | Maintain | Jul 25, 2025 |
| UBS | Neutral | Buy | Downgrade | Jan 6, 2025 |
| Goldman Sachs | Buy | Buy | Maintain | Mar 27, 2024 |
| Credit Suisse | Outperform | Outperform | Maintain | Feb 1, 2023 |
| Citigroup | Buy | Buy | Maintain | Jun 21, 2021 |
| Barclays | Overweight | Overweight | Maintain | Apr 12, 2021 |
| CFRA | Buy | Buy | Maintain | May 13, 2020 |
| SunTrust Robinson Humphrey | Hold | Hold | Maintain | Oct 26, 2017 |
| Deutsche Bank | Hold | Buy | Downgrade | Oct 14, 2016 |
| Wells Fargo | Market Perform | Outperform | Downgrade | Jan 13, 2016 |
| Keefe Bruyette & Woods | Outperform | Outperform | Maintain | Oct 12, 2015 |
| Sterne Agee | Neutral | Neutral | Maintain | Oct 13, 2014 |
Named analyst price targets
Upside is calculated against the persisted current price $497.9. FMP does not supply a rating on these named-analyst rows.
| Firm | Analyst | 52W target | Price when posted | Upside | Date |
|---|---|---|---|---|---|
| Morgan Stanley | Analyst unavailable | $483 | $499.08 | -3.0% | Oct 9, 2026 |
| Capital One Financial | Brennan Hawken | $520 | $496.67 | +4.4% | Oct 6, 2026 |
| Raymond James | Analyst unavailable | $570 | $490.91 | +14.5% | Oct 5, 2026 |
| Raymond James | Analyst unavailable | $638 | $558.26 | +28.1% | Aug 21, 2026 |
| Piper Sandler | Analyst unavailable | $518 | $506.76 | +4.0% | Jul 13, 2026 |
| Morgan Stanley | Michael Cyprys | $489 | $506.62 | -1.8% | Jul 10, 2026 |
| Jefferies | Suneet Kamath | $645 | $500.16 | +29.5% | Jul 10, 2026 |
| Piper Sandler | Crispin Love | $471 | $467.19 | -5.4% | May 4, 2026 |
| Morgan Stanley | Analyst unavailable | $467 | $479.63 | -6.2% | Apr 30, 2026 |
| BMO Capital | Brennan Hawken | $490 | $455.71 | -1.6% | Apr 24, 2026 |
| RBC Capital | Analyst unavailable | $560 | $456.59 | +12.5% | Apr 21, 2026 |
| Morgan Stanley | Analyst unavailable | $452 | $441.86 | -9.2% | Apr 10, 2026 |
| Raymond James | Wilma Burdis | $582 | $488.19 | +16.9% | Feb 11, 2026 |
| RBC Capital | Kenneth Lee | $605 | $529.47 | +21.5% | Feb 2, 2026 |
| Piper Sandler | John Barnidge | $530 | $521.36 | +6.4% | Jan 29, 2026 |
| Morgan Stanley | Analyst unavailable | $485 | $489.17 | -2.6% | Dec 22, 2025 |
| Evercore ISI | Analyst unavailable | $570 | $490.17 | +14.5% | Oct 9, 2025 |
| Morgan Stanley | Analyst unavailable | $484 | $486.62 | -2.8% | Oct 1, 2025 |
| Morgan Stanley | Michael Cyprys | $462 | $519.55 | -7.2% | May 15, 2025 |
| Morgan Stanley | Michael Cyprys | $509 | $514.04 | +2.2% | Oct 30, 2024 |
| Goldman Sachs | Alexander Blostein | $476 | $463.09 | -4.4% | Sep 25, 2024 |
| RBC Capital | Kenneth Lee | $500 | $432.05 | +0.4% | Jul 30, 2024 |
| UBS | Brennan Hawken | $495 | $429.25 | -0.6% | Jul 9, 2024 |
| Argus Research | Kevin Heal | $460 | $418.95 | -7.6% | May 6, 2024 |
| Morgan Stanley | Michael Cyprys | $445 | $412.86 | -10.6% | Apr 24, 2024 |
| Morgan Stanley | Michael Cyprys | $437 | $435.77 | -12.2% | Apr 9, 2024 |
| Piper Sandler | John Barnidge | $392 | $428.89 | -21.3% | Apr 5, 2024 |
| Morgan Stanley | Analyst unavailable | $345 | $320.45 | -30.7% | Jan 10, 2023 |
| UBS | Analyst unavailable | $370 | $324.71 | -25.7% | Jan 9, 2023 |
| Goldman Sachs | Analyst unavailable | $330 | $332.97 | -33.7% | Nov 23, 2022 |
| Morgan Stanley | Analyst unavailable | $340 | $316.94 | -31.7% | Nov 17, 2022 |
| Piper Sandler | Analyst unavailable | $220 | $223.12 | -55.8% | Jul 15, 2022 |
| Piper Sandler | Analyst unavailable | $231 | $238.27 | -53.6% | Jul 8, 2022 |
| Piper Sandler | John Barnidge | $253 | $235.1 | -49.2% | Jun 21, 2022 |
| Piper Sandler | Analyst unavailable | $275 | $274.33 | -44.8% | May 27, 2022 |
| UBS | Analyst unavailable | $350 | $267.4 | -29.7% | Apr 26, 2022 |
| Morgan Stanley | Analyst unavailable | $330 | $280.96 | -33.7% | Apr 26, 2022 |
| Jefferies | Suneet Kamath | $350 | $293.04 | -29.7% | Apr 9, 2022 |
| Piper Sandler | John Barnidge | $310 | $292.26 | -37.7% | Apr 6, 2022 |
Track every rating change on AMP the moment it posts. Free to start.
Start freeCompany context
Snapshot as of publicationAmeriprise Financial, Inc. is a holding company, which engages in providing financial planning, asset management, and insurance services to individuals, businesses, and institutions. It operates through the following business segments: Advice & Wealth Management, Asset Management, Retirement & Protection Solutions, and Corporate & Other. The Advice & Wealth Management segment consists of financial planning and advice, as well as full-service brokerage services for retail clients through financial advisors.…
Historical context
All AMP earningsFinancial Services peers this season
Latest reports in the same sector| Company | Quarter | EPS surprise | Market move | Headline |
|---|---|---|---|---|
| ING ING Groep N.V. | FY2026 Q3 · Calendar Q4 2026 | -5.1% | -2.0% | ING posts strong Q3, raises targets while restructuring wholesale banking |
| MA Mastercard Incorporated | FY2026 Q3 · Calendar Q4 2026 | — | +4.2% | Mastercard: Resilient Q3 growth, with execution risks in new payments |
| OWL Blue Owl Capital Inc. | FY2026 Q3 · Calendar Q4 2026 | — | +7.7% | Blue Owl posts strong growth as fundraising and pipelines expand |
| KB KB Financial Group Inc. | FY2026 Q3 · Calendar Q4 2026 | — | -0.7% | KB Financial posts strong Q3 profit as NIM remains under pressure |
| ARES Ares Management Corporation | FY2026 Q3 · Calendar Q4 2026 | — | +2.9% | ARES Q3: Fundraising and digital infrastructure remain key growth drivers |
| WTW Willis Towers Watson Public Limited Company | FY2026 Q3 · Calendar Q4 2026 | — | -0.3% | WTW posts Q3 growth while lowering full-year organic outlook |
Latest beats and misses
Who reports nextBeat on EPS
- BUDFY2026 Q3 · October 29, 2026+6.1% EPS-1.8% move
- WCCFY2026 Q3 · October 29, 2026+23.0% EPS+5.6% move
- ASXFY2026 Q3 · October 29, 2026+8.8% EPS+1.4% move
- GFLFY2026 Q3 · October 28, 2026+2.2% EPS+3.3% move
- KIM-PLFY2026 Q3 · October 29, 2026+101.6% EPS— move
- MRKFY2026 Q3 · October 29, 2026+19.1% EPS+3.8% move
Get the AMP recap when the next report posts
One email per quarter with the scorecard, the market reaction and what changed on the call. No account needed.
Sources
- Earnings call transcript and parsed analysis · 2026-10-29T18:10:40.182767+00:00
- FN2 earnings calendar · 2026-10-30T01:23:13.979536+00:00
- Polygon adjusted daily market bars · 2026-10-30T02:20:45.622104+00:00
- Financial Modeling Prep analyst price-target consensus and quote snapshot · 2026-10-30T02:20:45.619313+00:00
Methodology
Reported and consensus figures come from FN2's earnings event records. Market reaction and volume are calculated from daily adjusted bars around the event; abnormal move subtracts the SPY move over the same window.
Analyst target low, average, and high values are derived at request time from each named analyst's latest persisted FMP target. The current-price marker comes from FN2's persisted market snapshot. They are sell-side estimates, not an FN2 valuation or recommendation.
Transcript intelligence is a structured synthesis of the current and prior earnings-call analyses. Missing values stay missing and are never estimated.
By FN2 Research · Updated · As of 2026-10-30. For educational purposes only; not investment advice.